Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published: November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like ‘Until it is fixed’: Congress ramps up action on Social Security clawbacks December 15, 2023 Study reveals free-to-play video games mimic gambling spending patterns August 21, 2026 Innovative photodynamic therapy targets melanoma with light-activated dyes February 17, 2025